Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nicolls

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Circulation Research|March 17, 2018
Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary HypertensionRasa Tamosiuniene, Olga Manouvakhova, Paul Mesange, et al.
Science Translational Medicine|February 23, 2018
Microhemorrhage-associated tissue iron enhances the risk for <i>Aspergillus fumigatus</i> invasion in a mouse model of airway transplantationJoe L Hsu, Olga V Manouvakhova, Karl V Clemons, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2015
Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein SignalingNils P Nickel, Edda Spiekerkoetter, Mingxia Gu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Biochemical and Biophysical Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) InfectionsMichael J Kratochvil, Gernot Kaber, Pamela C Cai, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.
Iscience|January 23, 2023
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3Aneel R Bhagwani, Mehboob Ali, Bryce Piper, et al.
Cell Reports. Medicine|April 5, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipientsMengyun Hu, Ana Paula B N Oliveira, Zhuoqing Fang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
JCI Insight|May 5, 2017
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshopVibha N Lama, John A Belperio, Jason D Christie, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial HypertensionStuti Agarwal, Anuradha Bankar, Lyong Heo, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Circulation Research|March 17, 2018
Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary HypertensionRasa Tamosiuniene, Olga Manouvakhova, Paul Mesange, et al.
Science Translational Medicine|February 23, 2018
Microhemorrhage-associated tissue iron enhances the risk for <i>Aspergillus fumigatus</i> invasion in a mouse model of airway transplantationJoe L Hsu, Olga V Manouvakhova, Karl V Clemons, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2015
Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein SignalingNils P Nickel, Edda Spiekerkoetter, Mingxia Gu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Biochemical and Biophysical Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) InfectionsMichael J Kratochvil, Gernot Kaber, Pamela C Cai, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.
Iscience|January 23, 2023
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3Aneel R Bhagwani, Mehboob Ali, Bryce Piper, et al.
Cell Reports. Medicine|April 5, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipientsMengyun Hu, Ana Paula B N Oliveira, Zhuoqing Fang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
JCI Insight|May 5, 2017
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshopVibha N Lama, John A Belperio, Jason D Christie, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial HypertensionStuti Agarwal, Anuradha Bankar, Lyong Heo, et al.
Pageof 13